Tạp chí Tim mạch học Việt Nam

Article detail

Article detail description

Home
NGHIÊN CỨU LÂM SÀNG Issue: Số 71 - 2015 BỆNH RỐI LOẠN NHỊP TIM

Evaluation of antithrombotic therapy in patients with atrial fibrillation who had coronary stenting

Published: October 18, 2015
Views: 74

Abstract

Aim of the study: To evaluate the prescription of antithrombotic drugs for patients with atrial fibrillation (AF) who had coronary stenting according to stroke risk stratification and to search for drug interactions in patients’ dossiers. Patients and methods: Cross-sectional study in patients with AF who had coronary stenting and were followed at the Heart Institute, Ho Chi Minh city, from August 2014 to June 2015. AF was classified as valvular or non-valvular. Patients with non-valvular AF were risk stratified with the CHA2DS2-VASc score. Assessment in each patient if antithrombotic drugs were adequately used according to the 2014 ESC guidelines. Search for drug interactions with Medscape and Facts & Comparisons software (2013 version). Results: 100 patients met selection criteria, including 5 patients with valvular AF and 95 patients with non-valvular AF (85 with high stroke risk and 10 with moderate stroke risk). Among 5 patients with valvular AF, one was not prescribed an oral anticoagulant. Among 85 patients with non-valvular AF with high stroke risk, 13 patients (15,3%) were not prescribed an oral anticoagulant. Drug interactions were found in 90 dossiers (Medscape) and 97 dossiers (Facts & Comparisons). The most frequent serious drug interaction was clopidogrel-esomeprazole (in 20 dossiers). Conclusions: The majority of patients with AF who had coronary stenting at the Heart Insitute was prescribed adequate antihtrombotic therapy. Two main errors in drug prescription were neglecting an oral anticoagulant for patients with high stroke risk and use of esomeprazole in patients treated with clopidogrel.

Keywords
No translate

References

1.
Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991;22:983-988.
2.
Camm AJ, Lip GYH, De Caterina R, et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation. An update of the 2010 ESC guidelines for the management of atrial fibrillation. Eur Heart J 2012. DOI:10.1093/eurheartj/ehs253.
3.
Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS guidelines on myocardial revascularization. The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2014. DOI:10.1093/eurheartj/ehu278.
4.
January CT, Wann LS, Alpert JS, et al. 2014 ACC/AHA/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and Heart Rhythm Society. Circulation. Published online March 28, 2014.
5.
Lip GYH, Windecker S, Huber K, et al. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: A joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA), endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS). Eur Heart J 2014;35:3155-3179.
6.
http://reference.medscape.com/drug-interactionchecker.
7.
Facts & comparisons. St. Louis, MO: Wolters Kluwer Health, Inc.; 2013.
8.
European Medicines Agency. Interaction between clopidogrel and proton-pump inhibitors. Public statement, 17 March 2010. EMA/174948/2010.
9.
http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm327922.htm.
10.
Mizia-Stec K, Haberka M, Mizia M, et al. Effects of pantoprazole on dual antiplatelet therapy in stable angina pectoris patients after percutaneous coronary intervention. Pharmacological Reports 2012;64:360-368.
11.
Drepper MD, Spahr L, Frossard JL. Clopidogrel and proton pump inhibitors - Where do we stand in 2012? World J Gastroenterol 2012;18:2161-2171.

Tác giả

Đào Thị Kiều Nhi: Viện Tim TP. Hồ Chí Minh; Hồ Huỳnh Quang Trí: Viện Tim TP. Hồ Chí Minh;
Evaluation of antithrombotic therapy in patients with atrial fibrillation who had coronary stenting

Files

Article Views74
Document Views0
Downloads8
Section NGHIÊN CỨU LÂM SÀNG
Category BỆNH RỐI LOẠN NHỊP TIM
Pages 58-64
Copyright Holder 2015 Tạp chí Tim mạch học Việt Nam